James A. Geraghty's most recent trade in Fulcrum Therapeutics Inc was a trade of 36,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 26, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fulcrum Therapeutics Inc | James A. Geraghty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 36,000 | 36,000 | - | - | Stock Option (right to buy) | |
| Voyager Therapeutics Inc | James A. Geraghty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Pieris Pharmaceuticals Inc | James A. Geraghty | Director | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 07 Aug 2024 | 1 | 1 | - | 1 | 1 | Series F Preferred Stock, par value $0.001 per share |
| Fulcrum Therapeutics Inc | James A. Geraghty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Voyager Therapeutics Inc | James A. Geraghty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Fulcrum Therapeutics Inc | James A. Geraghty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Voyager Therapeutics Inc | James A. Geraghty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Fulcrum Therapeutics Inc | James A. Geraghty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2022 | 19,000 | 19,000 | - | - | Stock Option (right to buy) | |
| Voyager Therapeutics Inc | James A. Geraghty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Fulcrum Therapeutics Inc | James A. Geraghty | Director | Purchase of securities on an exchange or from another person at price $ 9.16 per share. | 28 Jun 2021 | 10,000 | 90,714 (0%) | 0% | 9.2 | 91,600 | Common Stock |
| Pieris Pharmaceuticals Inc | James A. Geraghty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Fulcrum Therapeutics Inc | James A. Geraghty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Voyager Therapeutics Inc | James A. Geraghty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) |